Hongene Biotech Corporation USA Revenue and Competitors

Union City, CA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Hongene Biotech Corporation USA's estimated annual revenue is currently $4M per year.(i)
  • Hongene Biotech Corporation USA's estimated revenue per employee is $155,000

Employee Data

  • Hongene Biotech Corporation USA has 26 Employees.(i)
  • Hongene Biotech Corporation USA grew their employee count by 8% last year.

Hongene Biotech Corporation USA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Hongene Biotech Corporation USA?

Hongene Biotech Corporation was established in 1998 as an R&D organization and has since become a manufacturer with state-of-art facilities in the fields of nucleosides, nucleotides and phosphoramidites. Having main operations in Shanghai, China at the start, today the company also has offices and laboratories in the USA and Japan. Hongene supplies only the best quality products at a competitive price to customers worldwide. Through collaborations with pharmaceutical diagnostic and biotechnology companies, Hongene is continuously developing new products in this area of science. At Hongene our experts are also happy to offer custom synthesis products essential for your R&D, helping to bring your products to market more efficiently. Through continuous innovation, improvement of manufacturing technologies, the tightest quality control and devoted technical team and services, we aim to help our customers to achieve their goals efficiently and economically.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M264%N/A
#2
$5.3M28-3%N/A
#3
$5.3M28-7%N/A
#4
$2.8M284%N/A
#5
$5.2M2953%N/A